Your browser doesn't support javascript.
loading
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.
Wu, Xiaoyan; Wang, Lin; Qiu, Yining; Zhang, Bingyu; Hu, Zhenhua; Jin, Runming.
Afiliación
  • Wu X; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
  • Wang L; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
  • Qiu Y; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
  • Zhang B; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
  • Hu Z; Department of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
  • Jin R; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
Int J Nanomedicine ; 12: 8025-8034, 2017.
Article en En | MEDLINE | ID: mdl-29184402
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quinasas Asociadas a Receptores de Interleucina-1 / Nanopartículas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Animals / Female / Humans Idioma: En Revista: Int J Nanomedicine Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quinasas Asociadas a Receptores de Interleucina-1 / Nanopartículas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Límite: Animals / Female / Humans Idioma: En Revista: Int J Nanomedicine Año: 2017 Tipo del documento: Article